Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma | |
Gavine, Paul R.; Wang, Mei; Yu, Dehua; Hu, Eva; Huang, Chunlei; Xia, Jenny; Su, Xinying; Fan, Joan; Zhang, Tianwei; Ye, Qingqing | |
刊名 | BMC CANCER |
2015 | |
卷号 | 15 |
关键词 | MAPK7 ERK5 Oncogene Kinase Inhibitor |
ISSN号 | 1471-2407 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4870502 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Gavine, Paul R.,Wang, Mei,Yu, Dehua,et al. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma[J]. BMC CANCER,2015,15. |
APA | Gavine, Paul R..,Wang, Mei.,Yu, Dehua.,Hu, Eva.,Huang, Chunlei.,...&Ji, Qunsheng.(2015).Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.BMC CANCER,15. |
MLA | Gavine, Paul R.,et al."Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma".BMC CANCER 15(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论